Actinium Pharmaceuticals
ATNM
#8874
Rank
€50.6 M
Marketcap
1,62 €
Share price
-4.26%
Change (1 day)
-72.33%
Change (1 year)

EPS for Actinium Pharmaceuticals (ATNM)

EPS in 2023 (TTM): -1,72 €

According to Actinium Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -1,64 €. In 2022 the company made an earnings per share (EPS) of -1,24 € a decrease over its 2021 EPS that were of -1,08 €.

EPS history for Actinium Pharmaceuticals from 2007 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-1,72 €38.84%
2022-1,24 €14.17%
2021-1,08 €-43.4%
2020-1,91 €-52.98%
2019-4,07 €-31.68%
2018-5,96 €-46.34%
2017-11,10 €-18%
2016-13,54 €-9.09%
2015-14,89 €-38.89%
2014-24,37 €91.49%
2013-12,72 €-88.41%
2012-109,76 €1251.63%
2011-8,12 €3.2423204348652E+19%
2010-0,0000000000 €
2009N/A-100%
2008-0,27 €-39.06%
2007-0,44 €

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-0,47 €-71.43%🇺🇸 USA
0,70 €-142.78%🇺🇸 USA
-0,58 €-64.84%🇺🇸 USA